mPhase Technologies, Inc. today released a short, non-narrated, rough footage, technical video highlighting its smart surface technology, that illustrates the design elements that make up the final assembly of its first multi cell Smart NanoBattery.
Keystone Dental, Inc. today announced U.S. regulatory clearance of Genesis, The Biomimetic Implant System. The Genesis System represents a major advance in implant dentistry through its biomimetic design.
CRAIC Technologies, the leading manufacturer of UV-visible-NIR microscopes and microspectrometers, is pleased to announce the 308 FPD a spectrophotometer designed to analyze the color and relative intensity of individual pixels of even microdisplays.
Oklahoma-based NanoBioMagnetics Inc. and Nanomateriales SA de CV of Monterrey City, Mexico, announced today that they have entered into an agreement that will expand global manufacturing and commercialization opportunities for both companies in the area of broad-spectrum UVA/UVB physical sunscreens.
The project will establish commercial production in Russia of power consumption meters and protective systems for power grids. The fiber optic current and voltage sensor systems are based on nanofibers.
454 Life Sciences, a Roche Company, announced today that it has entered an exclusive partnership with DNA Electronics for the development of a low-cost, high-throughput DNA sequencing system. As part of the agreement, Roche has signed a non-exclusive license for relevant IP from DNA Electronics' proprietary semiconductor technology portfolio, which enables sensitive detection of nucleotide incorporation during sequencing.
Shocking Technologies, Inc. has received notification from Underwriters Laboratories that it has been awarded 94V-0 certification for its XStaticTM100 product, a voltage switchable dielectric (VSD) material.
Lumerical Solutions Inc., a global provider of nanophotonic design software, today unveiled innovative improvements to its flagship product FDTD Solutions 7.0. Improvements to FDTD Solutions 7.0 include an integrated parameter sweep and optimization environment, industry's first conformal mesh for nanophotonic design, an extended set of simulation primitives to facilitate the design of complex devices and support for Mac OS X.
Aculon is pleased to announce that the United States Patent and Trademark Office (USPTO) has allowed a patent covering its method for applying organometallic film to substrates, which has been perfected by the company over the past 6 years.
Access Pharmaceuticals, Inc., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into a pre-licensing feasibility agreement with a leading biopharmaceutical company to develop an oral formulation of an undisclosed prostate cancer compound utilizing its proprietary vitamin B-12-based CobOral Drug Delivery Technology.
Carl Zeiss SMS GmbH, a leading supplier for photomask metrology and repair tools and Synopsys, Inc., a world leader in software and IP for semiconductor design, verification and manufacturing, today announced a collaboration to support the ZEISS tool family for in-die metrology solutions for the 32-nanometer technology node and below.
The rapid, real-time measurement capabilities of the Zetasizer Nano system from Malvern Instruments have enabled quantified nanoscale characterization of the environmental sensitivity of novel solubilization nanoparticles.
Cyrium Technologies, Inc., a leading developer of multi-junction concentrator photovoltaic (CPV) cells, today announced the incorporation of its quantum dot enhanced solar cells in the CPV solar tracker deployed as part of the SUNRISE (Semiconductors Using Nanostructures for Record Increases in Solar-cell Efficiency) project.
BioNanomatrix, Inc., which is developing and commercializing breakthrough single-molecule genomic analysis technology, will introduce next month the nanoAnalyzer 1000 System at the American Society of Human Genetics (ASHG) Annual Meeting from November 2-6, 2010 in Washington, D.C.